drugset / Trial / NCT00179231
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The study involves a six-month, double-blind protocol during which eighty patients, across three sites around the country, will be randomly assigned to receive clozapine or olanzapine. The specific aims of the study are to evaluate the relative effects of olanzapine and clozapine on clinical outcomes and cognition in patients diagnosed with schizophrenia or schizoaffective disorder who have demonstrated resistance to treatment in the past.
Timeline
- Start
- 2000-05
- Primary completion
- —
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clozapine | Other / unclassified | 564 mg | — |
| Subject | Olanzapine | Small molecule | 34 mg | — |